On 9 Oct 2007, at 3:48 pm, andrew holway wrote:
Seems to be some excitement in Europe over Xen, a
paravirtualisation package.
I ran our bioinformatics benchmark suite on some of our old RLX
blades running Xen, just to see what the performance hit was. It was
only about 2%, running a mixture of BLAST, HMMER, genewise and
exonerate, many of which are fairly I/O intensive. I was quite
surprised it was as small a hit as that.
That said, I'm still not using virtualisation on our production
clusters.
Tim
--
The Wellcome Trust Sanger Institute is operated by Genome Research
Limited, a charity registered in England with number 1021457 and a
company registered in England with number 2742969, whose registered
office is 215 Euston Road, London, NW1 2BE.
_______________________________________________
Beowulf mailing list, [email protected]
To change your subscription (digest mode or unsubscribe) visit
http://www.beowulf.org/mailman/listinfo/beowulf
